Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation

Starting soon · Phase 4

Conditions studied: Pulsed Field Ablation, Lidocaine

In brief

To evaluate the efficacy and safety of intravenous lidocaine in reducing diaphragmatic contraction and suppressing the cough reflex during pulsed field ablation procedures.

Key facts

Study ID

NCT07354217

Run by

National Taiwan University Hospital

People needed

60

Starts

2026-06-01

Expected to finish

2030-12-31

Last updated by the study team

2026-04-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with paroxysmal or persistent AF and are scheduled to undergo PVI.
• Patients who can understand the study aims and protocol and are willing to follow the protocol for one year.

You may not qualify if…

• Informed consent could not be obtained
• Known allergy to study drug lidocaine.
• Presence of thrombus in the LA or LA appendage
• Underlying significant pulmonary disease, such as asthma or COPD needing long term maintenance therapy or documented interstitial lung disease

Where it is running

• National Taiwan University Hospita — Taipei, Taiwan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.